Over-the-Counter (OTC) Veterinary Drugs Market Report 2026

The over-the-counter (OTC) veterinary drugs market size has grown strongly in recent years. It will grow from $8.93 billion in 2025 to $9.7 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing pet ownership rates, rising livestock population globally, growth in veterinary pharmaceutical availability in retail channels, increasing awareness of animal health and hygiene, expansion of animal healthcare infrastructure in rural regions.

The over-the-counter (OTC) veterinary drugs market size is expected to see strong growth in the next few years. It will grow to $13.57 billion by 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to rising demand for preventive animal healthcare solutions, increasing adoption of e-commerce veterinary drug sales, growth in companion animal healthcare spending, expansion of nutraceutical and supplement-based veterinary care, rising focus on antimicrobial resistance reduction through OTC alternatives. Major trends in the forecast period include rising adoption of over the counter antiparasitic and anti infective veterinary drugs for easy livestock and companion animal care, increasing demand for nutraceutical based OTC veterinary supplements supporting immunity and joint health, growing preference for dermatological OTC animal care products for skin and coat management, expansion of e-commerce platforms enabling direct access to veterinary OTC medicines, rising use of broad spectrum OTC formulations for preventive animal health management.

The increasing rates of pet ownership are expected to drive the growth of the over-the-counter (OTC) veterinary drugs market going forward. Pet ownership rates refer to the percentage or proportion of households or individuals owning one or more pets within a particular population or geographic area. Rising pet ownership rates are driven by growing companionship needs, as more individuals seek emotional support, comfort, and a sense of connection through pets in their everyday lives. Increasing pet ownership rates result in higher demand for over-the-counter (OTC) veterinary drugs, as more pet owners look for convenient and cost-effective solutions for routine pet healthcare management and preventive care. For instance, in March 2025, according to the American Pet Products Association (APPA), a US-based trade association, the number of U. S. households owning at least one pet increased from 82 million in 2023 to 94 million. Therefore, the increasing rates of pet ownership are driving the growth of the over-the-counter (OTC) veterinary drugs market.

Leading companies operating in the over-the-counter (OTC) veterinary drugs market are focusing on technological advancements in animal healthcare, such as science-backed, veterinarian-formulated supplement systems, to gain a competitive advantage. This technology utilizes advanced nutraceutical formulations and clinically studied ingredients to support preventive care and chronic-condition management in companion animals through non-prescription oral products. For instance, in February 2025, Elanco Animal Health, a US-based animal health company, launched Pet Protect, a veterinarian-formulated supplement line for dogs and cats that includes fast-acting calming chews, joint-health and skin-health formulations, as well as multivitamin and omega-3 blends designed to address common wellness needs. Pet Protect incorporates species-specific palatability engineering, proprietary ingredient blends, and transparent, evidence-driven labeling, thereby strengthening Elanco’s presence in the OTC veterinary supplement segment while aligning with pet owners’ demand for convenient at-home wellness solutions.

In April 2023, PetMed Express Inc., a US-based online pharmacy company, acquired PetCareRx Inc. for an undisclosed amount. Through this acquisition, PetMeds aims to strengthen its position in the online pet pharmacy market by expanding its product portfolio, reaching a broader customer base, and improving operational efficiency and customer engagement. PetCareRx Inc. is a US-based pet health and wellness company that offers a range of over-the-counter (OTC) pet medications.

Major companies operating in the over-the-counter (otc) veterinary drugs market are Merck And Co Inc, Boehringer Ingelheim Animal Health GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Limited, Ceva Santé Animale, Virbac S. A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Laboratorios Hipra S. A., Vetoquinol S. A., Indian Immunologicals Limited, Sequent Scientific Limited, Ourofino Saúde Animal, Bioveta A. S, Huvepharma EOOD, Ashish Life Science Private Limited, Zydus Animal Health and Investments Limited, Norbrook Laboratories Limited, Kyoritsu Seiyaku Corporation.

North America was the largest region in the over-the-counter (OTC) veterinary drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over-the-counter (OTC) veterinary drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the over-the-counter (OTC) veterinary drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over-the-counter (OTC) veterinary drugs market consists of sales of dewormers, ear care products, eye care products, oral care (dental) products, and wound care and antiseptic products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.